The global pharmacy market size is expected to be worth around USD 1,750 billion by 2032 from USD 1,108 billion in 2022, growing at a CAGR of 4.8% during the forecast period from 2022 to 2032.

In 2025, the Pharmacy Market is expanding beyond dispensing to offer clinical services and point-of-care (POC) testing. Pharmacies are now performing screenings for diabetes, cholesterol, and even oral contraceptive eligibility. Pharmacists are trained to provide vaccinations, smoking cessation counseling, and minor ailment prescriptions. Partnerships with primary care reduce burden on hospitals and improve access.

Regulatory bodies are recognizing pharmacists as healthcare providers, enabling reimbursement for clinical services. Consumers benefit from fast, trusted care at accessible locations. This shift positions pharmacies as holistic health hubs embedded in community care, with national pharmacy associations advocating for more scope expansion.

Click here for more information: https://market.us/report/pharmacy-market/

Emerging Trends

1. Expanded vaccination programs offered at pharmacies, including influenza and COVID boosters.
2. Pharmacist-led disease screenings for hypertension, cholesterol, and diabetes.
3. Minor ailment prescribing authority for infections, allergies, and dermatological conditions.
4. Pharmacy-based POC testing services for STIs, hemoglobin, and metabolic panels.

Use Cases

1. A community pharmacy administers shingles vaccines to seniors with direct insurance billing.
2. Walk-in hypertension checks at pharmacies allow instant pharmacist counseling and medication initiation.
3. A pharmacy chain offers tele-prescribing for UTIs after POC dipstick testing onsite.
4. A pharmacy hosts cholesterol screening events and refers high-risk patients to physicians via integrated EHR links.